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NADPH Oxidase 1 Overexpression Enhances
Invasion via Matrix Metalloproteinase-2 and
Epithelial–Mesenchymal Transition in Melanoma
Cells
Feng Liu1,2, Angela M. Gomez Garcia2 and Frank L. Meyskens Jr1,2,3,4
NADPH oxidase 1 (Nox1) is a member of the NADPH oxidase family that has not been well characterized in the
melanocytic cell lineage. Here we demonstrated that Nox1 and Nox4 were detected in melanocytic lineage, with
only Nox1 detected in normal human melanocytes and Nox4 in a subset of metastatic melanoma cell lines. The
protein level and enzymatic activity of Nox1 was elevated in all melanoma cells as compared with normal
melanocytes. Overexpression of GFP-Nox1 protein in Wm3211 primary melanoma cells increased invasion rate
by 4- to 6-fold as measured by Matrigel invasion assay, whereas knocking down or inhibiting Nox1 decreased
invasion by approximately 40–60% in Wm3211 and SK-Mel-28 cells. Matrix metalloproteinase-2 (MMP-2) was
increased by Nox1 overexpression at the mRNA, protein, and activity levels, and decreased by Nox1
knockdown. MMP-2 promoter activity was also regulated by Nox1 knockdown. In addition, stable clones
overexpressing Nox1 exhibited an epithelial–mesenchymal transition (EMT) as examined by cell morphology
and EMT markers; knockdown or inhibiting Nox1 led to a reversal of EMT. Supplementing MMP-2 to culture
media did not induce EMT, suggesting that EMT induction by Nox1 was not through MMP-2 upregulation. In
summary, Nox1 was overexpressed in all melanoma cell lines examined, and enhanced cell invasion by MMP-2
upregulation and EMT induction.
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INTRODUCTION
NADPH oxidase (EC 1.6.3.–) is a family of enzymes that
catalyze transfer of an electron from NAD(P)H to molecule
oxygen to generate superoxide or hydrogen peroxide. It
consists of seven members, represented by their catalytic
subunits: NADPH oxidase 1 (Nox1), Nox2 (gp91phox),
Nox3, Nox4, Nox5, Duox1, and Duox2. These enzymes
are expressed differentially in various tissues and organs
(Lambeth, 2004; Sumimoto, 2008). Nox2 is the founding
member of this enzyme family that has been extensively
studied in phagocytes and cardiovascular cells (Giannopou-
lou et al., 2008; Krause and Bedard, 2008; Rada et al., 2008).
Nox1 is the enzyme closest to Nox2 in a phylogenetic tree of
this family (Kawahara and Lambeth, 2007).
Nox1 requires a membrane subunit p22phox, Noxa1, and
Noxo1 for its full activity (Banfi et al., 1999; Ambasta et al.,
2004; Hanna et al., 2004). Nox1 is expressed in colon
epithelial cells, vascular smooth muscle cells, endothelium,
uterus, placenta, prostate, osteoclasts, and retinal pericytes,
and serves as an important signal molecule downstream of
platelet-derived growth factor, angiotensin II, and tumor
necrosis factor-a (Brown and Griendling, 2009). Recently,
overexpression of Nox1 was reported in colon cancer, gastric
cancer, and prostate cancer (Suh et al., 1999; Kamata, 2009).
To our best knowledge, expression of Nox1 was not reported
in melanoma, although expression ofNox4 has been reported
previously (Brar et al., 2002; Govindarajan et al., 2007;
Yamaura et al., 2009).
An early study revealed that Nox1 overexpression induced
transformation in NIH3T3 cells (Suh et al., 1999); subsequent
studies showed that Nox1 was required for K-ras-mediated
transformation of normal rat kidney cells (Komatsu et al.,
2008). Hence, Nox1 plays an important role in cancer
development. In colon cancer cells, reactive oxygen species
(ROS) generated by Nox1 contributed to cell invasion
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through upregulating matrix metalloproteinase-9 (MMP-9)
(Shinohara et al., 2010). MMPs are a family of proteinases
with various substrates and functions, including angiogenesis,
tissue invasion, inflammation, and tumor metastasis (Hadler-
Olsen et al., 2010; Kessenbrock et al., 2010). In melanoma,
both MMP-2 and MMP-9 were involved in cell invasion (van
den Oord et al., 1997; Simonetti et al., 2002); however, only
overexpression of MMP-2 is correlated with progression and
survival (Vaisanen et al., 1998, 2008; Orimoto et al., 2008;
Malaponte et al., 2010). To our best knowledge, regulation of
MMP-2 by Nox1 has not been reported in cancer cells
including melanoma.
Epithelial–mesenchymal transition (EMT) is a pathway
facilitating cell invasion, which is characterized by loss of
epithelial and gain of mesenchymal morphology, accompa-
nied by loss of E-cadherin, gain of N-cadherin, vimentin,
and other markers (Pla et al., 2001; Singh and Settleman,
2010). MMP-3 and MMP-9 may contribute to EMT via
modifying the extracellular matrix components (Radisky
et al., 2005; Blavier et al., 2010); whether MMP-2
played such a role is not clear. Although Nox1 played
a role indirectly in modifying cell adhesion molecules
(Sadok et al., 2009), it is not clear whether Nox1 mediates
EMT process.
RESULTS
Nox1 is overexpressed in melanoma cell lines
The Nox1 expression levels and total Nox activities in normal
human melanocytes (NHMs) and melanoma cell lines were
examined. As shown in Figure 1a, compared with NHMs,
Nox1 protein levels were increased in all melanoma cell
lines. Figure 1b shows the densitometry-quantified Nox1
protein levels (first normalized to a-tubulin loading control
and then to NHMs). Figure 1c shows total Nox enzymatic
levels as analyzed using NADH as a substrate and lucigenin
as the electron acceptor for superoxide anions (Cui and
Douglas, 1997; Cai et al., 2007). All melanoma cell lines
exhibited higher Nox activities than NHMs. This enzyme
assay does not distinguish among Nox family members;
hence, it reflects total Nox activity based on superoxide
generation. Therefore, reverse transcriptase–PCR (RT–PCR)
was performed to identify individual Nox members. As
shown in Figure 1d, Nox1 mRNA was detected in normal
melanocytes and all melanoma cell lines examined. Con-
sistently, mRNAs for Nox1 subunits Noxo1 and p22phox
were also detected in NHMs and melanoma cell lines. In
contrast, Nox4 mRNA was not detected in NHMs or primary
melanoma cell lines Wm3211 and Wm115 (Figure 1d);
instead, it was only detected in three metastatic cell lines
A375, c8161, and c8146A (Figure 1d). The HaCaT cells and
human umbilical vein endothelial cells were used as positive
controls for Nox1 and Nox4, whereas b-actin was used as a
loading control. We further examined the mRNA accumula-
tion of all seven members of Nox family in NHMs and
c8146A melanoma cell lines and confirmed again that the
only two members expressed in melanocytic lineage were
Nox1 and Nox4, whereas only Nox1 mRNA was detected in
NHMs (Figure 1e).
Subcellular localization of Nox1
To determine the subcellular localization of Nox1, a GFP-
tagged Nox1 construct pEGFP-Nox1 was generated and
transfected into Wm3211 cells. Two stable clones (Clone nos.
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Figure 1. Expression of NADPH oxidase 1 (Nox1) in melanocytes and
melanoma cells. (a) Western blot analysis of Nox1 protein in normal human
melanocytes (NHMs) and melanoma cell lines. (b) Quantitative Nox1 protein
accumulation in NHMs and melanoma cell lines. Protein accumulation was
quantified by a densitometer and first normalized to a-tubulin, and then to
NHM. (c) Relative NADPH oxidase activity in NHMs and melanoma cell lines
and HaCaT cells. The Nox activities in other cell lines were compared with
that in NHM cells. (d) Reverse transcriptase–PCR (RT–PCR) analysis of Nox1,
Noxo1, p22phox, and Nox4 genes in NHMs and melanoma cell lines,
HaCaT cells, and human umbilical vein endothelial cells (HUVECs) were
used as positive controls. b-Actin was used as internal control. (e) RT–PCR
analysis of Nox family genes in NHMs and c8146A melanoma cell lines.
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1 and 2) were established. The green fluorescence signal from
GFP-Nox1 fusion protein in Clone no. 1 cells was located
around the cell nucleus, distinct from what was observed in
cells expressing GFP protein alone, where fluorescence signal
was diffusely present throughout the cells (Figure 2a). Co-
staining with 40,6-diamidino-2-phenylindole (DAPI) and
plasma-membrane marker wheat-germ agglutinin (WGA)
(Flesch et al., 1998) conjugated with Texas Red revealed that
the Nox1 signal was mainly localized in the cytosolic
compartment, with minor signal overlapping with WGA-
Texas Red fluorescence (Figure 2b). When examined under a
microscopy with  63 objective oil lens, the cytosolic and
partial plasma-membrane localization was more obvious
(Figure 2c). No GFP-Nox1 signal was observed in the nucleus
(Figure 2c). The cytosolic and partial plasma-membrane
localization of Nox1 was further confirmed by immunofluor-
escence using anti-Nox1 antibody and FITC-conjugated
secondary antibody. The majority of the Nox1 green
fluorescence was within the cytosol, and again a portion of
the signal was on the plasma membrane (Figure 2d).
Overexpression of Nox1 in Wm3211 cells led to increased
invasion
As shown in Figure 2, overexpression of GFP-Nox1
showed green fluorescence signal in a pattern distinct from
that of GFP alone; however, we were unable to detect the
GFP-Nox1 protein on a western blot, presumably due
to low levels of expression of this fusion protein, or disruption
of the epitope recognized by the antibody. Yet, when total
Nox activity was measured, both no. 1 and no. 2 cells
showed higher level (3B8-fold) compared with the parental
Wm3211 cells (Figure 3a). Consistently, these clones also
exhibited higher levels of superoxide (2.5- to 3.1-fold) as
measured by dihydroethidium fluorescence (Figure 3b).
To examine whether Nox1-mediated ROS has a particular
role in melanoma invasion, Matrigel invasion assay
was performed. As shown in Figure 3c and d, Clone nos. 1
and 2 showed 3.6- and 4.5-fold higher invasion rate than the
control Wm3211 cells, whereas the negative control
GFP clone did not show a significant increase of invasion.
To rule out clone variation, GFP-Nox1 was transiently
expressed in Wm3211 cells and the invasion rate was
compared with that in cells overexpressing GFP alone. GFP
signal was verified using a fluorescence microscope (Figure
3e). There was an average of 60 cells per view under a
microscope for GFP-Nox1 overexpressed cells, whereas there
was only an average of 14 cells per view for cells transfected
with GFP vector alone (Figure 3e and f), representing an
average of 4.3-fold increase of invasion driven by GFP-Nox1
expression.
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Figure 2. Subcellular localization of NADPH oxidase 1 (Nox1). (a) GFP-Nox1 overexpression Clone no. 1 showing the GFP fluorescence around cells, in
contrast to clones expressing GFP protein alone. (b) GFP-Nox1 signal from Clone no. 2 cells (green), plasma-membrane marker wheat-germ agglutinin (WGA)-
Texas Red (red), 40,6-diamidino-2-phenylindole (DAPI) staining (blue), and their overlaying photos (processed by Image J, 40 objectives). (c) GFP-Nox1 signals
from cell Clone no.1 (green), WGA-Texas Red, DAPI staining, and their overlaying photos ( 63 objectives). (d) Immunofluorescence staining of Nox1 in
Wm3211 cells. Cells were fixed and stained with Nox1 primary antibody, and then FITC-conjugated secondary antibody. Phase-contrast photos were taken and
overlayed with Nox1 and DAPI signal. Bar¼ 10mm.
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Knocking down or inhibiting Nox1 led to decreased invasion
To further confirm the role of Nox1 in melanoma invasion,
melanoma cells were pretreated with a Nox inhibitor
diphenyl-iodonium chloride (DPI) at 5 mM for 4 hours
before invasion assay. DPI treatment decreased the
number of invaded cells for both Wm3211 and SK-Mel-28
(Figure 4a and b). Furthermore, plasmids expressing short-
hairpin RNAs targeting two different sequences in Nox1
coding region were constructed (pRS-sh2 and pRS-sh3) and
transfected into Wm3211 and SK-Mel-28 cells, and then
selected with puromycin for 2 weeks. The shRNA targeting
GFP sequence (pRS-GFPi) was used as a control. Nox1
protein knockdown (70–80%) was confirmed by western blot
in both cell lines (Figure 4c). Decreased invasion rates
(40–60%) were observed in both cell lines transfected with
either pRS-sh2 or pRS-sh3 plasmids, as compared with the
control cells (Figure 4d and e).
Nox1 regulates MMP-2
MMP-2 and MMP-9 are among the MMPs characterized in
melanoma cells for their key roles in invasion (Leslie and Bar-
Eli, 2005). We examined the expression levels of both MMPs
in response to Nox1 regulation. As shown in Figure 5a, the
gelatinase activity assay indicated that the 72-kDa MMP-2
activity increased in culture media of Clone no. 1 and no. 2
cells, as compared with Wm3211 cells, and decreased in
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no. 1 and no. 2 clones. (d) Relative invasion capacity of GFP cells, and no. 1 and no. 2 cells compared with that of control Wm3211 cells. (e) Overexpression of
GFP-Nox1 in a transient transfection experiment; GFP vector was used as a control. These cells were used for invasion assay 48 hours post-transfection,
the invaded cells were photographed (right panels), and cell number was counted in five randomly picked views under a microscope. (f) The average invaded
cell numbers were graphed. 1, GFP; 2, GFP-Nox1. Bar¼ 10 mm. DHE, dihydroethidium.
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cells with Nox1 knockdown (Figure 5a). The MMP-9 activity
was not detected in these cells (Figure 5a). Quantification by
densitometry indicated that the MMP-2 activity increased
about 4- to 5-fold in Clone nos. 1 and 2, and then decreased
about 50% in sh2 and sh3 cells (Figure 5a). Western blot
analysis confirmed that in Clone nos. 1 and 2, the secreted
MMP-2 protein accumulated to higher levels than that in the
control Wm3211 cells, and lower levels in sh2 and sh3 cells
(Figure 5b). Duplicated gels stained with Coomassie blue
(partial) is shown as loading controls (Figure 5b). In SK-Mel-
28 cells with Nox1 knockdown (sh2 and sh3), MMP-2
activity was also decreased about 50–70% as compared with
the control parental cells (Figure 5c). Quantitative RT–PCR
analysis indicated that the MMP-2 mRNA increased about
10-fold in Clone no. 1 and no. 2 cells as compared with that
in the parental cells. A small increase (2.5- to 3.5-fold) of
MMP-9 mRNA was also observed in these cells (Figure 5d).
Overexpression of Nox1 was further confirmed in these
clones as the Nox1 mRNA accumulated to about 5- to 19-
fold in Clone nos. 1 and 2 as compared with Wm3211 cells
(Figure 5d). Analysis of the MMP-2 promoter reporter activity
in sh2 and sh3 cells indicated that the knockdown of Nox1
decreased MMP-2 promoter activity by 30–40% (Supplemen-
tary Figure S1a online). These data suggest that regulation of
MMP-2 by Nox1 is likely through a transcriptional mechan-
ism. As MMP-2 is a well-documented transcriptional target
for AP-1 transcriptional factors, we also examined the AP-1
transcription activity in Clone no. 1 and no. 2 cells. A reporter
plasmid for AP-1 activity, pAP-1-SEAP, was transiently
transfected into Wm3211 cells together with pRL-SV40
luciferase reporter plasmids (internal control). Our results
showed that normalized AP-1 activities in Clone nos. 1 and 2
were about 2.5- to 4.0-fold of that in the parental Wm3211
cells (Supplementary Figure S1b online). Further examination
of AP-1 transcription factors in Nox1 overexpression clones
indicated that among all AP-1 members, only JunB showed
increased protein accumulation in Clone no. 1 and no. 2 cells
(data not shown). Chromatin immunoprecipitation experi-
ments using antibody against JunB showed that binding of
JunB to MMP-2 promoter decreased in sh2 cells to nearly
background level and increased about 2-fold in Nox1-
overexpressing Clone no. 1 cells (Figure 5e).
To further confirm that Nox1-generated ROS and upregu-
lated MMP-2 played key roles in its ability to stimulate
invasion, Clone no. 1 cells were treated with the ROS
scavenger N-acetyl-cysteine (NAC, 2mM, 24 hours) or MMP
inhibitor GM6001 (10 mM, 4 hours) before invasion assay. Our
results showed that both NAC and GM6001 reduced invasion
rate in these cells, by approximately 67 and 50%, respec-
tively (Figure 5f and g). Zymography assay indicated that
NAC treatment led to a decreased (about 65%) MMP-2
activity in Wm3211 cells (Figure 5h). Quantitative RT–PCR
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revealed that this regulation is likely also through transcrip-
tion because the accumulation of MMP-2 transcripts
decreased nearly 70% in the NAC-treated cells (Supplemen-
tary Figure S2 online).
Nox1 regulates EMT
In addition to MMPs, EMT also plays an important role in cell
migration and invasion. We observed that Clone nos. 1 and 2
showed an elongated, mesenchymal morphology as com-
pared with the parental Wm3211 cells (Figure 6a), which
mimicked a transforming growth factor-b-induced EMT
morphological change ((Supplementary Figure S3a online).
Western blot analysis indicated that EMT markers N-cadherin
and vimentin were increased in Clone no. 1 and no. 2 cells as
compared with Wm3211 cells, and E-cadherin decreased
(Figure 6b). In contrast, Wm3211 cells with Nox1 knock-
down (sh2 and sh3 cells) showed a reversed EMT morphol-
ogy: the cells were more epithelial-like as compared with the
control GFPi cells (Figure 6c). Consistently, western blot
analysis showed that the sh2 and sh3 cells exhibited reversed
EMT marker changes: increased E-cadherin and decreased
N-cadherin and vimentin (Figure 6d). Furthermore, when
Nox1 was inhibited by DPI in SK-Mel-28 cells, these cells
also showed a dose- and time-dependent reversal of EMT
phenotype (Figure 6e). Western blot analysis indicated that
N-cadherin and vimentin were decreased, and E-cadherin
increased in the DPI-treated cells as compared with control
cells (Figure 6f). Knocking down Nox1 in SK-Mel-28 cells led
to similar reversed EMT morphological changes where cells
became flatter, less elongated, and more epithelial-like
(Supplementary Figure S4 online). It was reported that some
MMPs were able to induce EMT in certain cell lineages (Tan
et al., 2010; Lin et al., 2011). To test whether Nox1-
upregulated MMP-2 played a role in EMT induction in
Wm3211 cells, we added purified active MMP-2 into cell
culture media and incubated for up to 48 hours; no induction
of EMT was observed (Supplementary Figure S3b online).
DISCUSSION
The Nox gene family plays key roles in regulating many
physiological processes including cardiovascular function
and immune responses. An early study identified that Nox4
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played a role in melanoma proliferation (Brar et al., 2002). A
few studies subsequently confirmed the role of Nox4 in
melanoma cell cycle progression and invasion (Govindarajan
et al., 2007; Yamaura et al., 2009). Expression of other Nox
family members was not reported, although Nox enzyme
activity was shown to be important for melanoma cell
differentiation (Zhao et al., 2008). In this study, we report
expression of Nox1 and its subunits p22phox and Noxo1 in
normal human melanocytes and melanoma cell lines, and
characterized its function in promoting melanoma invasion
via upregulating MMP-2 and induction of EMT.
Nox1 expression was elevated in all melanoma cell lines
including early radial growth phase cell line Wm3211;
however, the protein level did not correlate with melanoma
progression. This observation suggests that upregulation of
Nox1 is an early event in melanoma transformation. In
contrast, Nox4 was only detected in three metastatic cell
lines, which is consistent with previous study showing that
Nox4 was downstream of AKT pathway driving for melano-
ma invasion (Govindarajan et al., 2007).
Studies from our laboratory and others have demonstrated
that ROS levels are higher in melanoma cells than in NHMs
(Meyskens et al., 1997; Sander et al., 2003; Fried and Arbiser,
2008). The source of ROS is multiple and includes various
physiological procedures or organelles, such as biosynthesis
of melanin (Slominski et al., 2004), altered tumor metabo-
lism, and immune reactions (Komarov et al., 2005; Wittgen
and van Kempen, 2007). Our observation that Nox1 is
ubiquitously overexpressed in all melanoma cell lines
suggests that Nox1 overexpression may contribute to the
observed high ROS levels in melanoma cells.
The subcellular localization of Nox1 is still under debate.
The protein contains six transmembrane domains; therefore,
it is likely a membrane protein. Here we show that a GFP-
tagged Nox1 protein is indeed partially localized to
plasma membrane. However, the majority of the signal was
localized to the cytoplasmic compartment. Further experi-
ments are needed to determine whether the protein is
localized to certain membrane organelles such as Golgi
body or endoplasmic reticulum.
To understand the mechanism of Nox1-induced melano-
ma invasion, two key MMPs (MMP-2 and MMP-9) in
melanoma invasion were examined. MMP-2 was identified
as the major effector of Nox1 in melanoma invasion, which is
different from that in colon cancer cells where MMP-9 was a
main effector (Kim et al., 2009). The Nox1-inducedMMP-2 is
likely through an ROS-dependent transcriptional mechanism,
mediated by the AP-1 family transcription factors (Bergman
et al., 2003; Kajanne et al., 2007; Singh et al., 2010). The
Nox1/AP-1/MMP-2 signal pathway is consistent with pre-
vious studies showing that AP-1 and MMP-2 played
important roles in melanoma progression (Yamanishi et al.,
1991; Yang and Meyskens, 2005; Malaponte et al., 2010); we
are actively investigating the interplay between Nox gene
family and AP-1 family to understand their interaction in
melanomagenesis.
Nox1 regulates colon cancer cell migration through a2/a3
integrins (Sadok et al., 2009); however, it was not clear
whether Nox1 induced morphological changes such as EMT,
which enabled cancer cells to adapt to a different morphol-
ogy and to facilitate migration and invasion. We observed
that overexpression of Nox1 induced an EMT change and
knockdown or inhibiting Nox1 led to a reversal of EMT,
suggesting that Nox1 induced cell invasion through multiple
mechanisms. Although MMPs, in particular MMP-9 and
MMP-3, were able to induce EMT in some cells, MMP-2 did
not show such ability in Wm3211 melanoma cells (Supple-
mentary Figure S3b online). Hence, the Nox1-induced cell
invasion is likely through induction of MMP-2 and EMT
independently.
In summary, we compared the expression of Nox1 in
melanocytes and melanoma cell lines. Nox1 protein level
and enzymatic activity are both higher in melanoma cells
than in NHMs, suggesting that Nox1 may contribute to high
ROS levels in melanoma cells. We further demonstrated that
Nox1 overexpression in melanoma cells enhanced cell
invasion via two seemingly independent mechanisms: (1)
upregulation of MMP-2 at the transcriptional level, likely
through the AP-1 transcription factor; and (2) induction of
EMT. Other functions of Nox1 in NHMs and melanoma cells
warrant further investigation because of its direct association
with superoxide generation and hence modulating the
cellular redox status and cell signaling events.
MATERIALS AND METHODS
Cell culture and invasion assay
All melanoma cell culture conditions were the same as described
previously (Liu et al., 2009). Normal human melanocytes were
isolated from newborn foreskin, followed by a protocol approved by
University of California Internal Review Board. Purified MMP-2 protein
and GM6001 were purchased from Enzo Life Sciences (Farmingdale,
NY). NAC was purchased from Sigma, St Louis, MO. The Matrigel
invasion assay was carried out according to the manufacturer’s
instruction (Becton, Dickinson and Company, Franklin Lakes, NJ).
RT–PCR, quantitative real-time RT–PCR, and chromatin
immunoprecipitation
The primers for all genes used in this study are listed in
Supplementary Table S1 online. For both PCR and quantitative
real-time RT–PCR, b-actin was used as internal control. The relative
mRNA level was calculated by DDCt method as described before
(Liu et al., 2010). The chromatin immunoprecipitation protocol
followed one described previously (Liu and Lee, 2006).
Western blot and zymography assay
A modified protein extraction method and polyacrylamide gel
system was used to analyze Nox1 protein. Cells were lysed in RIPA
250 buffer by sonication (without centrifugation) (Liu et al., 2010). A
2 urea buffer (25mM Tris, pH 6.8, 12M urea) was added to cell
lysate at 1:1 (V:V) ratio, and placed on ice for 10minutes. The cell
lysate was further mixed with a 2 urea loading buffer (25mM Tris,
pH 6.8, 8 M urea, 30% glycerol) and loaded to a urea–SDS-PAGE gel
(containing 6 M urea) without boiling. Western blot analysis followed
a standard procedure. The antibody for Nox1 was H-75, which was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA). E-
cadherin, N-cadherin, and vimentin antibodies were obtained from
www.jidonline.org 2039
F Liu et al.
Nox1 in Melanoma Invasion
BD Biosciences, San Diego, CA. a-Tubulin antibody was from
Sigma. Gelatin-containing gels and developing kits were purchased
from Bio-Rad (Hercules, CA). Zymography assay was performed as
per the manufacturer’s instruction.
DNA constructs, SEAP assay, and luciferase assay
The Nox1 cDNA was purchased from Open Biosystems, Lafayette,
CO. The coding region was then PCR amplified (primers: Nox1U and
Nox1L) (Supplementary Table S1 online) and cloned into pEGFP-N2
vector via EcoRI and HindIII sites, resulting in pEGFP-Nox1. The pRS-
sh2 and pRS-sh3 were constructed from synthesized DNA oligos
sh2A-sh2B and sh3A-sh3B (Supplementary Table S1 online). The
MMP-2 promoter was cloned using primers prom2a and prom2b
(Supplementary Table S1 online) via NheI and BglII into pGL4.10
vector, resulting in pGL4-MMP2. Dual luciferase assay was performed
according to the manufacturer’s instruction (Promega, Madison, WI).
The pAP-1-SEAP was purchased from Clontech (Mountain View, CA)
and the SEAP assay was performed using a Great EscAPe SEAP
chemiluminescence detection kit from Clontech.
Cell staining and fluorescence microscopy
Cells were fixed in 4% formaldehyde, stained with WGA-conjugated
to Texas Red (Molecular Probes, Grand Island, NY) at room
temperature for 10minutes, washed, then permeabilized with
saponin, and finally stained with DAPI for 10minutes. For
immunofluorescence, Nox1 antibody was diluted 1:50 and incu-
bated at 4 1C overnight. Fluorescence was viewed under a Zeiss
fluorescence microscope.
Nox activity assay and superoxide detection
Nox activity assay was modified based on previous reports (Cui and
Douglas, 1997). Briefly, 50mg of lysate (10ml) was added into 90ml of
assay buffer and luminescence was read every 4 seconds for
1.5minutes in an ML 3000 Microtiter Plate Luminometer from
Dynatech Laboratories (Chantilly, VA). Same reaction was also carried
out in the presence of 10mM DPI. The difference of reaction velocities
(slopes) with or without DPI was calculated and expressed as relative
Nox activities. Each reaction was carried out for at least three times.
Assay for superoxide followed a previous study (Cai et al., 2007).
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